SlideShare a Scribd company logo
1 of 23
CGMP - 6
Production Process Controls
Responsibilities from the beginning of production to consumer consumption
Production Process Control Definition
Production Process Control is a discipline that deals with architectures,
mechanisms and algorithms for maintaining the output of a specific process
within a desired range
which for Grifols means…
Each employee trains, understands and follows the guidance provided
through the CFR, EU Guidelines and Standard Operating Procedures to
ensure quality medications reach our customer.
2
What Procedures Are Followed And Where Is The
Guidance Derived??
Grifols has written procedures, known as Standard Operating Procedures (SOP), that are followed
for every task.
Guidance is derived from the Code of Federal Regulations and EU Guidelines along with state and
local guidelines.
There are also guidelines to follow in case of any deviation from any procedure.
We have a quality control unit to ensure we follow the procedures and document any deviations.
Compliance is a team effort.
All Grifols team members are expected to perform at the highest level of excellence everyday, every
task, everytime.
3
SOP’s are our “rules” governing how we function as a
plasma center. Without SOP’s, centers would have no
direction and no guidelines to follow.
SOP’s are created so we can provide safety for our
donors and the people who receive the medications
we make. In many instances, SOP’s also ensure the
safety of our staff.
Our SOP’s are required to comply with CFR
standards.
SOP’s must be established, maintained, and followed
for all steps in the collection, processing, testing,
storage, and distribution of plasma and plasma
derived products.
STANDARD OPERATING PROCEDURES
Criteria to determine donor eligibility, including
acceptable medical history criteria.
Methods for performing calibrations including the
requirement to have a range of minimum and
maximum values when determining acceptability.
Any solution used to prepare the phlebotomy site
must give maximum assurance of sterility.
CFR Requires the following be included in our Standard
Operating Procedures
Presentation Title | Presenter’s Name | Date | BUSINESS USE ONLY
Procedures to investigate any
donor adverse reactions
Storage temperatures and
methods for controlling storage
temperatures
Quality control procedures for
supplies and reagents
Schedules and procedures for
equipment maintenance and
calibration
Labeling procedures, including
ways to avoid labeling mix-ups
CFR Requires the following be included in our Standard
Operating Procedures
The CFR defines plasma and gives criteria for eligibility of donors
Processing of plasma if regulated in the CFR and gives specifics on the final outcome
• Plasma shall be stored in a container that has no color added to the plastic and shall be transparent so as to
allow for visual inspection of the contents
• The collection container shall be sealed and maintain closure to prevent contamination of the contents
• The container material shall not interact with the contents as to have an adverse affect on the safety, purity,
potency, and effectiveness of the product
• Prior to filling the collection container, it should be identified by the donor number
• The final product should be inspected for any abnormalities in color or physical appearance
• No preservatives can be added to the final product
• Each center shall establish and maintain procedures to ensure that mix-ups, damage, contamination, or other
adverse effects do not occur during handling.
OTHER CFR SPECIFICATIONS FOR PLASMA CENTERS
• Blood containers and soft goods must be pyrogen-free, sterile, and identified by a lot
number
• Each unit of blood and plasma must be identified by a number so as to directly relate
to the donor
• A sample of blood must be drawn from each donor on the day of the initial physical
examination and at least every 4 months thereafter; a serological test for syphilis, a
serum protein determination and a serum protein electrophoresis (SPE) shall be
performed on the sample
• A repeat donor who does not return at the time the 4-month sample is due, may be
plasmapheresed the day he returns, provided that no longer than 6 months has
elapsed; the sample shall be collect on the day of the donor’s return
• A repeat donor from whom a sample has not been obtained for a total period
exceeding 6 months shall be processed as a new donor
• The sample must be reviewed within 14 calendar days after it is drawn to determine
whether or not the donor should be deferred from further donations.
• If a determination is not made within 14 calendar days, the donor must be deferred
pending determination.
• If the protein levels are not within normal limits established by the testing laboratory,
the donor may not be reinstated from a deferral until the his protein values are at an
acceptable level and approved by the responsible physician.
WHAT ARE THE CFR SOURCE SPECIFICS FOR PLASMA?
GENERAL REQUIREMENTS CONTINUED…
• A donor identification system shall be established that identifies
the donor accurately to his records and laboratory data
• This system shall include a photograph of each donor and the
photograph shall be used on each visit to confirm the donor’s
identity
• The plasma shall be separated from the red blood cells
immediately after collection
• The maximum amount of red blood cells shall be returned to
the donor before another unit is collected
• Plasma collection shall not occur less than 2 days apart or
more frequently than twice in a 7-day period
General Requirements Continued
• Inspection of Source Plasma shall be checked for evidence of thawing
• Samples shall be marked so as to directly relate them to the donor
• Samples should be filled at the time the final product is prepared and by the
same person
• All samples shall be collected in a manner that does not contaminate the
contents of the final container
• Plasma centers must ensure donors has a record of being found eligible and
has a record of negative test results on two occasions in the past 6 months
Records
• Documentation shall be available to ensure shipping temperature requirements
are being met
• For each donor, we must maintain records including a separate and complete
record of initial and periodic examinations, tests, laboratory data, etc.
• The original copy of the donor’s consent for participation in plasmapheresis
must be kept
• Medical history and physical examination records showing eligibility must be
documented
• If a donor has a reaction, the record’s shall contain a full explanation of
measures taken to assist the donor and the outcome of the incident
Unsure what info to use from 610.1 subpart A to 610.61 subpart G ????
HELP….
13
Overview of Responsibilities
• Training
• Documentation
• Deviations
• Cleaning and Quality Controls
• Processing, Storing, Shipping Units and Samples
• Product Testing
• Fractionation
• Customer consumption
• Impact
Your Responsibility Starts…?
On your first day and then everyday thereafter...
•Training is the foundation of Quality.
•Each employee is responsible for owning their training.
•Whether it is initial, cross or developmental training, do not
sign for training you do not understand.
•Don’t just accept the how to perform a task…understand why.
•Once you sign for training…you will be responsible for your
performance.
•Always make the right decision…if you make a mistake
remember… integrity first…admit the mistake and work with
your team toward corrective actions.
14
Documentation
If it’s not documented it didn’t happen! In plasma it’s a reality!!!
Documentation is maintained for each donor for each step in the
plasmapheresis process. This includes:
•The original copy of the donor’s consent for participation in plasmapheresis.
•All suitability determinations are documented to include physicals, suitability testing,
plasmapheresis process, unit handling, storage, shipping and fractionation.
•Supply receipt, storage temperature, and room monitoring.
•Unit processing, storage and shipping information
•Testing of units
• Fractionation process
• From beginning to end…documentation shows every step for every unit
15
Deviations
Deviation Tracking System (DTS) is used to document any deviations from
Standard Operating Procedures.
•The team will identify deviations on the Deviation Tracking Log
located in each area.
•Each deviation requires a review, investigation (using open-ended
questions), discovery of root cause and a corrective action.
•Review of the deviation must include a process review as well as
performance review.
•To ensure compliance, an efficacy check must be completed to
ensure long term procedural/behavioral changes
•Managing this system includes identifying trends early, identifying
cause and implementing corrective actions.
16
Cleaning and Quality Controls
• Equipment must be maintained in a clean and orderly manner to ensure removal of
biohazard and chances for cross contamination.
• Cleanliness is for you, the donor and the consumer…it only takes and few minutes to
protect many people…take cleanliness seriously
• Equipment must be standardized and calibrated on a regular scheduled basis
following applicable SOP’s and operator’s manuals.
• Quality Control (QC) process must be reviewed and approved by Quality daily.
• If there is a deviation during the QC process, Quality may stop the use of certain
equipment and/or stop production.
• Should any piece of equipment not meet QC requirements, follow SOP requirements,
and if needed take the equipment out of service. Do not risk a donor’s life by using
equipment that does not meet standards.
17
Processing, Storing, Shipping Units and Samples
ATTENTION TO DETAIL IS KEY!
Check and double check labels to ensure all
• Units and samples must be segregated during processing to ensure there is no mix up of labels
and no cross contamination.
• Ensure the correct labels are placed on sample tubes to ensure correct identification for testing.
• To reduce protein break down, ensure all temperatures are maintained per SOP during storage
and shipment of units and samples.
• Pack units and samples properly to minimize the potential for damage during the shipping
process.
18
Customer Consumption
• Every day, thousands of people are impacted by the
medicine we produce. We owe it to these patients to
safely and effectively produce life saving plasma.
• Many patients count on you and your integrity every
day…do not let them down.
• Know that at any given day it could be any member of
your family receiving the medications produced from
your center…give that some thought
19
Impact
Customers lives depend on you everyday.
Each task you perform is integrity-based so remember:
Integrity is measured by the decisions you make when no one else is looking
Perform Each Task
Right the First Time Every Time Every Day
20
21
211SubpartE,F,H,K
600.13
606.6
606SubpartH
610
640SubpartD,G,H
EU
GuidelinesChapter1,56
640SubpartI,
J,
820SubpartG,H,I
RESOURCES
22
23
THANK YOU!

More Related Content

What's hot

Dr. negi quality assurance
Dr. negi quality assuranceDr. negi quality assurance
Dr. negi quality assurancesanjay negi
 
Good Laboratory Practices by Dr. A. Amsavel
Good Laboratory Practices  by Dr. A. AmsavelGood Laboratory Practices  by Dr. A. Amsavel
Good Laboratory Practices by Dr. A. AmsavelDr. Amsavel A
 
good laboratory practices
good laboratory practices good laboratory practices
good laboratory practices rasika walunj
 
Good laboratory practices in a pharmaceutical lab 1
Good laboratory practices in a pharmaceutical lab 1Good laboratory practices in a pharmaceutical lab 1
Good laboratory practices in a pharmaceutical lab 1Sabahat Ali
 
Equipment reagent and materials in glp
Equipment reagent and materials in glpEquipment reagent and materials in glp
Equipment reagent and materials in glpBageshri Mestry
 
Glp guidelines in_qc_laboratory_as_per_ich
Glp guidelines in_qc_laboratory_as_per_ichGlp guidelines in_qc_laboratory_as_per_ich
Glp guidelines in_qc_laboratory_as_per_ichAnu Anusha
 
Quality and blood bank
Quality and blood bankQuality and blood bank
Quality and blood bankHoda Faramawy
 
GLP in Pharmaceutical Industry by Dr.A S Charan
GLP in Pharmaceutical Industry by Dr.A S CharanGLP in Pharmaceutical Industry by Dr.A S Charan
GLP in Pharmaceutical Industry by Dr.A S CharanCharan Archakam
 
Blood transfusion services qc
Blood transfusion services qcBlood transfusion services qc
Blood transfusion services qcNc Das
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practicesSyeda Abeer
 
Quality in microbiological lab
Quality in microbiological labQuality in microbiological lab
Quality in microbiological labdina lithy
 
quality assurance and quality control
quality assurance and quality controlquality assurance and quality control
quality assurance and quality controlAppy Akshay Agarwal
 

What's hot (19)

Dr. negi quality assurance
Dr. negi quality assuranceDr. negi quality assurance
Dr. negi quality assurance
 
Good Laboratory Practices by Dr. A. Amsavel
Good Laboratory Practices  by Dr. A. AmsavelGood Laboratory Practices  by Dr. A. Amsavel
Good Laboratory Practices by Dr. A. Amsavel
 
Good Laboratory Practices (http://www.ubio.in)
Good Laboratory Practices (http://www.ubio.in)Good Laboratory Practices (http://www.ubio.in)
Good Laboratory Practices (http://www.ubio.in)
 
What is glp
What is glpWhat is glp
What is glp
 
good laboratory practices
good laboratory practices good laboratory practices
good laboratory practices
 
Good laboratory practices in a pharmaceutical lab 1
Good laboratory practices in a pharmaceutical lab 1Good laboratory practices in a pharmaceutical lab 1
Good laboratory practices in a pharmaceutical lab 1
 
GLP
GLPGLP
GLP
 
Equipment reagent and materials in glp
Equipment reagent and materials in glpEquipment reagent and materials in glp
Equipment reagent and materials in glp
 
Glp guidelines in_qc_laboratory_as_per_ich
Glp guidelines in_qc_laboratory_as_per_ichGlp guidelines in_qc_laboratory_as_per_ich
Glp guidelines in_qc_laboratory_as_per_ich
 
Quality and blood bank
Quality and blood bankQuality and blood bank
Quality and blood bank
 
GLP in Pharmaceutical Industry by Dr.A S Charan
GLP in Pharmaceutical Industry by Dr.A S CharanGLP in Pharmaceutical Industry by Dr.A S Charan
GLP in Pharmaceutical Industry by Dr.A S Charan
 
Blood transfusion services qc
Blood transfusion services qcBlood transfusion services qc
Blood transfusion services qc
 
Good laboratory practice
Good laboratory practiceGood laboratory practice
Good laboratory practice
 
Glp
GlpGlp
Glp
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
 
Quality in microbiological lab
Quality in microbiological labQuality in microbiological lab
Quality in microbiological lab
 
Glp
GlpGlp
Glp
 
GLP in Bioequivalence Studies
GLP in Bioequivalence StudiesGLP in Bioequivalence Studies
GLP in Bioequivalence Studies
 
quality assurance and quality control
quality assurance and quality controlquality assurance and quality control
quality assurance and quality control
 

Viewers also liked (20)

M.A.Zakout Resume_11_5_2015
M.A.Zakout Resume_11_5_2015M.A.Zakout Resume_11_5_2015
M.A.Zakout Resume_11_5_2015
 
cGMP 4 Validation 1
cGMP 4 Validation 1cGMP 4 Validation 1
cGMP 4 Validation 1
 
Mechanical Designer
Mechanical DesignerMechanical Designer
Mechanical Designer
 
FUNDIÇÃO
FUNDIÇÃOFUNDIÇÃO
FUNDIÇÃO
 
TC Duties Revised
TC Duties RevisedTC Duties Revised
TC Duties Revised
 
INCIDENT ANGLE & DBR
INCIDENT ANGLE & DBRINCIDENT ANGLE & DBR
INCIDENT ANGLE & DBR
 
Guest room
Guest roomGuest room
Guest room
 
Tools, not only for Oracle RAC
Tools, not only for Oracle RACTools, not only for Oracle RAC
Tools, not only for Oracle RAC
 
Adultoooo expooo
Adultoooo expoooAdultoooo expooo
Adultoooo expooo
 
VALIDATION10282016
VALIDATION10282016VALIDATION10282016
VALIDATION10282016
 
Oracle Globalization Support, NLS_LENGTH_SEMANTICS, Unicode
Oracle Globalization Support, NLS_LENGTH_SEMANTICS, UnicodeOracle Globalization Support, NLS_LENGTH_SEMANTICS, Unicode
Oracle Globalization Support, NLS_LENGTH_SEMANTICS, Unicode
 
SONY Case Study
SONY Case StudySONY Case Study
SONY Case Study
 
Oracle 12c Multi Process Multi Threaded
Oracle 12c Multi Process Multi ThreadedOracle 12c Multi Process Multi Threaded
Oracle 12c Multi Process Multi Threaded
 
Case study of dell
Case study of dellCase study of dell
Case study of dell
 
PPE
PPEPPE
PPE
 
Feb Safety Slides
Feb Safety SlidesFeb Safety Slides
Feb Safety Slides
 
Buried Alive
Buried AliveBuried Alive
Buried Alive
 
Facility Layout in production management
Facility Layout in production managementFacility Layout in production management
Facility Layout in production management
 
Facility layout ppt
Facility layout pptFacility layout ppt
Facility layout ppt
 
Work Study
Work StudyWork Study
Work Study
 

Similar to Production Process Control 10282016

BMT GxP Training 10-22-2021 1.pptx
BMT GxP Training 10-22-2021 1.pptxBMT GxP Training 10-22-2021 1.pptx
BMT GxP Training 10-22-2021 1.pptxhaploidentical
 
cGMP Training 2013
cGMP Training 2013cGMP Training 2013
cGMP Training 2013bloodbank
 
QUALITY-CONTROL.pptx
QUALITY-CONTROL.pptxQUALITY-CONTROL.pptx
QUALITY-CONTROL.pptxJessaMay22
 
Quality-Control-in-Blood-Bank.pptx
Quality-Control-in-Blood-Bank.pptxQuality-Control-in-Blood-Bank.pptx
Quality-Control-in-Blood-Bank.pptxDhanrajKcity
 
Understanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesUnderstanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesPathKind Labs
 
Pre analytic and postanalytic test management
Pre analytic and postanalytic test managementPre analytic and postanalytic test management
Pre analytic and postanalytic test managementVarsha Shahane
 
Clinical research ppt,
Clinical research   ppt,Clinical research   ppt,
Clinical research ppt,Malay Singh
 
Presentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st year
Presentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st yearPresentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st year
Presentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st yearAnubhav Singh
 
Overview of Quality Control and its implementation in the laboratory.pptx
Overview of Quality Control and its implementation in the laboratory.pptxOverview of Quality Control and its implementation in the laboratory.pptx
Overview of Quality Control and its implementation in the laboratory.pptxDipesh Tamrakar
 
good laboratory practices
good laboratory practicesgood laboratory practices
good laboratory practicesrasika walunj
 
bb_unit15QualityAssuranceTransfusionServiceSpring2011 (1).ppt
bb_unit15QualityAssuranceTransfusionServiceSpring2011 (1).pptbb_unit15QualityAssuranceTransfusionServiceSpring2011 (1).ppt
bb_unit15QualityAssuranceTransfusionServiceSpring2011 (1).pptKarabiBarmanSaikia
 
5. QMS Lecture.pptxh hxhhxhhff ha chcffff
5. QMS Lecture.pptxh hxhhxhhff ha chcffff5. QMS Lecture.pptxh hxhhxhhff ha chcffff
5. QMS Lecture.pptxh hxhhxhhff ha chcffffhellohsbrandingsolut
 
Clinical trial protocol, ammendments, Protocol deviations and violations
Clinical trial protocol, ammendments, Protocol deviations and violationsClinical trial protocol, ammendments, Protocol deviations and violations
Clinical trial protocol, ammendments, Protocol deviations and violationsAmol Patil
 
Lect.2-what is QC -QA_R.pdf
Lect.2-what is QC -QA_R.pdfLect.2-what is QC -QA_R.pdf
Lect.2-what is QC -QA_R.pdfZaryabAhmad13
 
GMP and cGMP consideration
GMP and cGMP considerationGMP and cGMP consideration
GMP and cGMP considerationRavish Yadav
 

Similar to Production Process Control 10282016 (20)

BMT GxP Training 10-22-2021 1.pptx
BMT GxP Training 10-22-2021 1.pptxBMT GxP Training 10-22-2021 1.pptx
BMT GxP Training 10-22-2021 1.pptx
 
cGMP Training 2013
cGMP Training 2013cGMP Training 2013
cGMP Training 2013
 
QUALITY-CONTROL.pptx
QUALITY-CONTROL.pptxQUALITY-CONTROL.pptx
QUALITY-CONTROL.pptx
 
Quality-Control-in-Blood-Bank.pptx
Quality-Control-in-Blood-Bank.pptxQuality-Control-in-Blood-Bank.pptx
Quality-Control-in-Blood-Bank.pptx
 
Understanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesUnderstanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratories
 
Pre analytic and postanalytic test management
Pre analytic and postanalytic test managementPre analytic and postanalytic test management
Pre analytic and postanalytic test management
 
good-ward.ppt
good-ward.pptgood-ward.ppt
good-ward.ppt
 
Clinical research ppt,
Clinical research   ppt,Clinical research   ppt,
Clinical research ppt,
 
Presentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st year
Presentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st yearPresentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st year
Presentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st year
 
2. Ppt on GLP
2. Ppt on GLP2. Ppt on GLP
2. Ppt on GLP
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
Overview of Quality Control and its implementation in the laboratory.pptx
Overview of Quality Control and its implementation in the laboratory.pptxOverview of Quality Control and its implementation in the laboratory.pptx
Overview of Quality Control and its implementation in the laboratory.pptx
 
good laboratory practices
good laboratory practicesgood laboratory practices
good laboratory practices
 
bb_unit15QualityAssuranceTransfusionServiceSpring2011 (1).ppt
bb_unit15QualityAssuranceTransfusionServiceSpring2011 (1).pptbb_unit15QualityAssuranceTransfusionServiceSpring2011 (1).ppt
bb_unit15QualityAssuranceTransfusionServiceSpring2011 (1).ppt
 
Concept of glp
Concept of glpConcept of glp
Concept of glp
 
5. QMS Lecture.pptxh hxhhxhhff ha chcffff
5. QMS Lecture.pptxh hxhhxhhff ha chcffff5. QMS Lecture.pptxh hxhhxhhff ha chcffff
5. QMS Lecture.pptxh hxhhxhhff ha chcffff
 
Clinical trial protocol, ammendments, Protocol deviations and violations
Clinical trial protocol, ammendments, Protocol deviations and violationsClinical trial protocol, ammendments, Protocol deviations and violations
Clinical trial protocol, ammendments, Protocol deviations and violations
 
GLP.pptx
GLP.pptxGLP.pptx
GLP.pptx
 
Lect.2-what is QC -QA_R.pdf
Lect.2-what is QC -QA_R.pdfLect.2-what is QC -QA_R.pdf
Lect.2-what is QC -QA_R.pdf
 
GMP and cGMP consideration
GMP and cGMP considerationGMP and cGMP consideration
GMP and cGMP consideration
 

Production Process Control 10282016

  • 1. CGMP - 6 Production Process Controls Responsibilities from the beginning of production to consumer consumption
  • 2. Production Process Control Definition Production Process Control is a discipline that deals with architectures, mechanisms and algorithms for maintaining the output of a specific process within a desired range which for Grifols means… Each employee trains, understands and follows the guidance provided through the CFR, EU Guidelines and Standard Operating Procedures to ensure quality medications reach our customer. 2
  • 3. What Procedures Are Followed And Where Is The Guidance Derived?? Grifols has written procedures, known as Standard Operating Procedures (SOP), that are followed for every task. Guidance is derived from the Code of Federal Regulations and EU Guidelines along with state and local guidelines. There are also guidelines to follow in case of any deviation from any procedure. We have a quality control unit to ensure we follow the procedures and document any deviations. Compliance is a team effort. All Grifols team members are expected to perform at the highest level of excellence everyday, every task, everytime. 3
  • 4. SOP’s are our “rules” governing how we function as a plasma center. Without SOP’s, centers would have no direction and no guidelines to follow. SOP’s are created so we can provide safety for our donors and the people who receive the medications we make. In many instances, SOP’s also ensure the safety of our staff. Our SOP’s are required to comply with CFR standards. SOP’s must be established, maintained, and followed for all steps in the collection, processing, testing, storage, and distribution of plasma and plasma derived products. STANDARD OPERATING PROCEDURES
  • 5. Criteria to determine donor eligibility, including acceptable medical history criteria. Methods for performing calibrations including the requirement to have a range of minimum and maximum values when determining acceptability. Any solution used to prepare the phlebotomy site must give maximum assurance of sterility. CFR Requires the following be included in our Standard Operating Procedures
  • 6. Presentation Title | Presenter’s Name | Date | BUSINESS USE ONLY Procedures to investigate any donor adverse reactions Storage temperatures and methods for controlling storage temperatures Quality control procedures for supplies and reagents Schedules and procedures for equipment maintenance and calibration Labeling procedures, including ways to avoid labeling mix-ups CFR Requires the following be included in our Standard Operating Procedures
  • 7. The CFR defines plasma and gives criteria for eligibility of donors Processing of plasma if regulated in the CFR and gives specifics on the final outcome • Plasma shall be stored in a container that has no color added to the plastic and shall be transparent so as to allow for visual inspection of the contents • The collection container shall be sealed and maintain closure to prevent contamination of the contents • The container material shall not interact with the contents as to have an adverse affect on the safety, purity, potency, and effectiveness of the product • Prior to filling the collection container, it should be identified by the donor number • The final product should be inspected for any abnormalities in color or physical appearance • No preservatives can be added to the final product • Each center shall establish and maintain procedures to ensure that mix-ups, damage, contamination, or other adverse effects do not occur during handling. OTHER CFR SPECIFICATIONS FOR PLASMA CENTERS
  • 8. • Blood containers and soft goods must be pyrogen-free, sterile, and identified by a lot number • Each unit of blood and plasma must be identified by a number so as to directly relate to the donor • A sample of blood must be drawn from each donor on the day of the initial physical examination and at least every 4 months thereafter; a serological test for syphilis, a serum protein determination and a serum protein electrophoresis (SPE) shall be performed on the sample • A repeat donor who does not return at the time the 4-month sample is due, may be plasmapheresed the day he returns, provided that no longer than 6 months has elapsed; the sample shall be collect on the day of the donor’s return • A repeat donor from whom a sample has not been obtained for a total period exceeding 6 months shall be processed as a new donor • The sample must be reviewed within 14 calendar days after it is drawn to determine whether or not the donor should be deferred from further donations. • If a determination is not made within 14 calendar days, the donor must be deferred pending determination. • If the protein levels are not within normal limits established by the testing laboratory, the donor may not be reinstated from a deferral until the his protein values are at an acceptable level and approved by the responsible physician. WHAT ARE THE CFR SOURCE SPECIFICS FOR PLASMA?
  • 9. GENERAL REQUIREMENTS CONTINUED… • A donor identification system shall be established that identifies the donor accurately to his records and laboratory data • This system shall include a photograph of each donor and the photograph shall be used on each visit to confirm the donor’s identity • The plasma shall be separated from the red blood cells immediately after collection • The maximum amount of red blood cells shall be returned to the donor before another unit is collected • Plasma collection shall not occur less than 2 days apart or more frequently than twice in a 7-day period
  • 10. General Requirements Continued • Inspection of Source Plasma shall be checked for evidence of thawing • Samples shall be marked so as to directly relate them to the donor • Samples should be filled at the time the final product is prepared and by the same person • All samples shall be collected in a manner that does not contaminate the contents of the final container • Plasma centers must ensure donors has a record of being found eligible and has a record of negative test results on two occasions in the past 6 months
  • 11. Records • Documentation shall be available to ensure shipping temperature requirements are being met • For each donor, we must maintain records including a separate and complete record of initial and periodic examinations, tests, laboratory data, etc. • The original copy of the donor’s consent for participation in plasmapheresis must be kept • Medical history and physical examination records showing eligibility must be documented • If a donor has a reaction, the record’s shall contain a full explanation of measures taken to assist the donor and the outcome of the incident
  • 12. Unsure what info to use from 610.1 subpart A to 610.61 subpart G ???? HELP….
  • 13. 13 Overview of Responsibilities • Training • Documentation • Deviations • Cleaning and Quality Controls • Processing, Storing, Shipping Units and Samples • Product Testing • Fractionation • Customer consumption • Impact
  • 14. Your Responsibility Starts…? On your first day and then everyday thereafter... •Training is the foundation of Quality. •Each employee is responsible for owning their training. •Whether it is initial, cross or developmental training, do not sign for training you do not understand. •Don’t just accept the how to perform a task…understand why. •Once you sign for training…you will be responsible for your performance. •Always make the right decision…if you make a mistake remember… integrity first…admit the mistake and work with your team toward corrective actions. 14
  • 15. Documentation If it’s not documented it didn’t happen! In plasma it’s a reality!!! Documentation is maintained for each donor for each step in the plasmapheresis process. This includes: •The original copy of the donor’s consent for participation in plasmapheresis. •All suitability determinations are documented to include physicals, suitability testing, plasmapheresis process, unit handling, storage, shipping and fractionation. •Supply receipt, storage temperature, and room monitoring. •Unit processing, storage and shipping information •Testing of units • Fractionation process • From beginning to end…documentation shows every step for every unit 15
  • 16. Deviations Deviation Tracking System (DTS) is used to document any deviations from Standard Operating Procedures. •The team will identify deviations on the Deviation Tracking Log located in each area. •Each deviation requires a review, investigation (using open-ended questions), discovery of root cause and a corrective action. •Review of the deviation must include a process review as well as performance review. •To ensure compliance, an efficacy check must be completed to ensure long term procedural/behavioral changes •Managing this system includes identifying trends early, identifying cause and implementing corrective actions. 16
  • 17. Cleaning and Quality Controls • Equipment must be maintained in a clean and orderly manner to ensure removal of biohazard and chances for cross contamination. • Cleanliness is for you, the donor and the consumer…it only takes and few minutes to protect many people…take cleanliness seriously • Equipment must be standardized and calibrated on a regular scheduled basis following applicable SOP’s and operator’s manuals. • Quality Control (QC) process must be reviewed and approved by Quality daily. • If there is a deviation during the QC process, Quality may stop the use of certain equipment and/or stop production. • Should any piece of equipment not meet QC requirements, follow SOP requirements, and if needed take the equipment out of service. Do not risk a donor’s life by using equipment that does not meet standards. 17
  • 18. Processing, Storing, Shipping Units and Samples ATTENTION TO DETAIL IS KEY! Check and double check labels to ensure all • Units and samples must be segregated during processing to ensure there is no mix up of labels and no cross contamination. • Ensure the correct labels are placed on sample tubes to ensure correct identification for testing. • To reduce protein break down, ensure all temperatures are maintained per SOP during storage and shipment of units and samples. • Pack units and samples properly to minimize the potential for damage during the shipping process. 18
  • 19. Customer Consumption • Every day, thousands of people are impacted by the medicine we produce. We owe it to these patients to safely and effectively produce life saving plasma. • Many patients count on you and your integrity every day…do not let them down. • Know that at any given day it could be any member of your family receiving the medications produced from your center…give that some thought 19
  • 20. Impact Customers lives depend on you everyday. Each task you perform is integrity-based so remember: Integrity is measured by the decisions you make when no one else is looking Perform Each Task Right the First Time Every Time Every Day 20
  • 22. 22